Table 1A.
Baseline characteristics
| Characteristic | SCD (n = 134) | MCI (n = 102) | Dementia (n = 212) | Significant differences between groups |
| Female, n (%) | 74 (55.2%) | 31 (30.4%) | 105 (49.5%) | SCD, dementia > MCI |
| Age, y | 62.4 (8.7) | 68.3 (8.0) | 70.5 (9.2) | SCD<MCI, dementia |
| Duration of symptoms, y | 4.1 (4.3) | 3.1 (3.5) | 2.7 (2.2) | none |
| MMSE | 28.7 (1.4) | 27.3 (2.4) | 24.9 (2.9) | SCD>MCI>dementia |
| Etiology, n (AD/VaD/DLB/MD/FTD/OT) | – | 49/13/8/3/3/26 | 111/19/17/19/21/25 | |
| Progression, n (MCI/Dementia) | 9/3 | –/23 | – |
Baseline characteristics of groups based on the syndrome diagnosis (as diagnosed by consensus conference). Differences between groups were assessed using one-way ANOVA with Tukey post-hoc testing (age), χ2 test (gender) and Kruskal-Wallis with Dunn post-hoc testing (duration of symptom and MMSE). Data are presented as mean (SD), unless otherwise specified. AD, Alzheimer’s disease; VaD, vascular dementia; DLB, dementia with Lewy bodies; MD, mixed dementia; FTD, frontotemporal dementia; OT, other dementia.